By Drug Target Review2024-05-02T12:00:52
Researchers have revealed that genetically enhanced expression of GSDMB causes a disturbed interferon-response.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-26T13:58:00Z
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-07T10:55:58
Sponsored by Agilent
2023-07-04T10:05:58
Sponsored by Revvity
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-04-04T15:03:09
Sponsored by Agilent
Site powered by Webvision Cloud